Iclusig Tablet, Film Coated
Product Images NDC 63020-535

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Iclusig (NDC 63020-535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Iclusig 01)

Chemical structure diagram of ponatinib hydrochloride showing its molecular composition including rings, bonds, and functional groups as labeled in the image.*

FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Label for Iclusig (ponatinib) tablets, 15 mg strength, film-coated oral tablets. The label indicates storage instructions, dosage use note, and includes a count of 30 tablets. The product is distributed by Takeda Pharmaceuticals America, Inc., with the NDC 63020-535-30. The label also displays the brand name, active ingredient, and a reminder to keep away from children.*

FDA Label Image

Principal Display Panel (45 mg Tablet Bottle Label)

Iclusig 45 mg (ponatinib) film-coated tablets label showing a 30-count bottle. The label indicates each tablet contains 45 mg ponatinib equivalent to 48.08 mg ponatinib hydrochloride. Storage instructions specify 20° to 25°C with permitted excursions. The product is distributed by Takeda Pharmaceuticals America, Inc., made in Canada, and is prescription only.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Iclusig 30 mg (ponatinib) tablets label in a rectangular format with a light blue background. The label shows the strength as 30 mg of ponatinib per tablet. It includes storage instructions at 20° to 25°C with permitted excursions, dosage and use guidance referencing accompanying prescribing information, and a warning to keep away from children. The package contains 30 tablets for Rx only. Distributed by Takeda Pharmaceuticals America, Inc., Lexington, MA, and marked as a product of Canada with the Takeda logo.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Iclusig 10 mg film-coated tablets label containing ponatinib hydrochloride, distributed by Takeda Pharmaceuticals America, Inc. The label indicates 30 tablets per package and includes storage instructions to keep at 20° to 25°C with allowed excursions. RX only with a medication guide is mentioned.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.